Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
Jeffrey S. Heier, MD
Contributor
Dr. Jeffrey S. Heier is the director of the retina service and director of retina research at Ophthalmic Consultants of Boston. He is the past president of the Retina Society, a member of the American Society of Retina Specialists executive committee, the past president of the New England Ophthalmological Society, and a member of the Macula Society. He is one of the leading retinal clinical researchers in the country for new treatments in retinal disease. He is a scientific advisor to many biotechnical or pharmaceutical companies, lectures nationally and internationally, and has authored numerous peer-reviewed works.
Dr. Heier received his medical degree from Boston University, completed an internship and residency at Fitzsimons Army Medical Center, and a vitreoretinal fellowship at OCB/Tufts School of Medicine. He served as a physician in a combat support hospital in the Persian Gulf War, where he was awarded a Bronze Star.
Even a little exercise linked with lower stroke risk in people with afib
Testosterone therapy without evidence of deficiency may boost heart risk
Weight-loss drug may lower risk of heart attacks and infections
What to eat on the DASH diet
Migraine: How it's diagnosed and what that means
Tricep workouts you can do at home
Mindfulness practices to reduce stress and improve focus
Antihistamines may not offer meaningful relief from eczema symptoms
Overweight and taking blood pressure medications: Study finds it's a trend that's working
FDA approves first mRNA-based flu vaccine
